151 related articles for article (PubMed ID: 12672796)
1. Differential sorting of human delta-opioid receptors after internalization by peptide and alkaloid agonists.
Marie N; Lecoq I; Jauzac P; Allouche S
J Biol Chem; 2003 Jun; 278(25):22795-804. PubMed ID: 12672796
[TBL] [Abstract][Full Text] [Related]
2. Different kinases desensitize the human delta-opioid receptor (hDOP-R) in the neuroblastoma cell line SK-N-BE upon peptidic and alkaloid agonists.
Marie N; Aguila B; Hasbi A; Davis A; Jauzac P; Allouche S
Cell Signal; 2008 Jun; 20(6):1209-20. PubMed ID: 18395423
[TBL] [Abstract][Full Text] [Related]
3. Different regulation of human delta-opioid receptors by SNC-80 [(+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and endogenous enkephalins.
Lecoq I; Marie N; Jauzac P; Allouche S
J Pharmacol Exp Ther; 2004 Aug; 310(2):666-77. PubMed ID: 15102931
[TBL] [Abstract][Full Text] [Related]
4. ßarrestin1-biased agonism at human δ-opioid receptor by peptidic and alkaloid ligands.
Aguila B; Coulbault L; Davis A; Marie N; Hasbi A; Le bras F; Tóth G; Borsodi A; Gurevich VV; Jauzac P; Allouche S
Cell Signal; 2012 Mar; 24(3):699-707. PubMed ID: 22101011
[TBL] [Abstract][Full Text] [Related]
5. Differential desensitization of human delta-opioid receptors by peptide and alkaloid agonists.
Allouche S; Roussel M; Marie N; Jauzac P
Eur J Pharmacol; 1999 Apr; 371(2-3):235-40. PubMed ID: 10357261
[TBL] [Abstract][Full Text] [Related]
6. Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE.
Allouche S; Polastron J; Hasbi A; Homburger V; Jauzac P
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):71-8. PubMed ID: 10432302
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors.
Xu H; Wang X; Partilla JS; Bishop-Mathis K; Benaderet TS; Dersch CM; Simpson DS; Prisinzano TE; Rothman RB
Brain Res Bull; 2008 Sep; 77(1):49-54. PubMed ID: 18639745
[TBL] [Abstract][Full Text] [Related]
8. Impact of T161, Y318 and S363 alanine mutations on regulation of the human delta-opioid receptor (hDOPr) induced by peptidic and alkaloid agonists.
Camacho E; Marie N; Dupas Q; Martel C; Nowoczyn M; Elie N; Rochais C; Töth G; Allouche S
Neuropharmacology; 2020 Nov; 179():108286. PubMed ID: 32841607
[TBL] [Abstract][Full Text] [Related]
9. Opioid regulation of the mouse delta-opioid receptor expressed in human embryonic kidney 293 cells.
Bot G; Blake AD; Li S; Reisine T
Mol Pharmacol; 1997 Aug; 52(2):272-81. PubMed ID: 9271350
[TBL] [Abstract][Full Text] [Related]
10. Internalization and recycling of delta-opioid receptor are dependent on a phosphorylation-dephosphorylation mechanism.
Hasbi A; Allouche S; Sichel F; Stanasila L; Massotte D; Landemore G; Polastron J; Jauzac P
J Pharmacol Exp Ther; 2000 Apr; 293(1):237-47. PubMed ID: 10734175
[TBL] [Abstract][Full Text] [Related]
11. The molecular mechanisms of cellular tolerance to delta-opioid agonists. A minireview.
Varga EV
Acta Biol Hung; 2003; 54(2):203-18. PubMed ID: 14535626
[TBL] [Abstract][Full Text] [Related]
12. G protein independent phosphorylation and internalization of the delta-opioid receptor.
Bradbury FA; Zelnik JC; Traynor JR
J Neurochem; 2009 Jun; 109(5):1526-35. PubMed ID: 19344370
[TBL] [Abstract][Full Text] [Related]
13. Agonist-specific down-regulation of the human delta-opioid receptor.
Okura T; Varga EV; Hosohata Y; Navratilova E; Cowell SM; Rice K; Nagase H; Hruby VJ; Roeske WR; Yamamura HI
Eur J Pharmacol; 2003 Jan; 459(1):9-16. PubMed ID: 12505529
[TBL] [Abstract][Full Text] [Related]
14. Role of Src in ligand-specific regulation of delta-opioid receptor desensitization and internalization.
Hong MH; Xu C; Wang YJ; Ji JL; Tao YM; Xu XJ; Chen J; Xie X; Chi ZQ; Liu JG
J Neurochem; 2009 Jan; 108(1):102-14. PubMed ID: 19014372
[TBL] [Abstract][Full Text] [Related]
15. Deltorphin II-induced rapid desensitization of delta-opioid receptor requires both phosphorylation and internalization of the receptor.
Law PY; Kouhen OM; Solberg J; Wang W; Erickson LJ; Loh HH
J Biol Chem; 2000 Oct; 275(41):32057-65. PubMed ID: 10893226
[TBL] [Abstract][Full Text] [Related]
16. Quantitative evaluation of human delta opioid receptor desensitization using the operational model of drug action.
Navratilova E; Waite S; Stropova D; Eaton MC; Alves ID; Hruby VJ; Roeske WR; Yamamura HI; Varga EV
Mol Pharmacol; 2007 May; 71(5):1416-26. PubMed ID: 17322005
[TBL] [Abstract][Full Text] [Related]
17. Effects of multiple intracerebroventricular injections of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin II on tolerance to their analgesic action and on brain delta-opioid receptors.
Zhao GM; Bhargava HN
Brain Res; 1997 Jan; 745(1-2):243-7. PubMed ID: 9037415
[TBL] [Abstract][Full Text] [Related]
18. Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells which endogenously coexpress the receptors.
Shapira M; Vogel Z; Sarne Y
Cell Mol Neurobiol; 2000 Jun; 20(3):291-304. PubMed ID: 10789829
[TBL] [Abstract][Full Text] [Related]
19. Exploring deltorphin II binding to the third extracellular loop of the delta-opioid receptor.
Fadhil I; Schmidt R; Walpole C; Carpenter KA
J Biol Chem; 2004 May; 279(20):21069-77. PubMed ID: 14999000
[TBL] [Abstract][Full Text] [Related]
20. Long-term interactions between opioid and cannabinoid agonists at the cellular level: cross-desensitization and downregulation.
Shapira M; Gafni M; Sarne Y
Brain Res; 2003 Jan; 960(1-2):190-200. PubMed ID: 12505672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
